Influence of various technological parameters on the preparation of spray-dried poly(epsilon-caprolactone) microparticles containing a model antigen

References

• ALMEIDA, A. J., ALPAR, H. Q., and BROWN, M. R. W., 1993, Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(L-lactic acid) microspheres in rats, rabbits and guinea-pigs. Journal of Pharmaceutical Pharmacology, 45, 198–203.
   PubMedGoogle Scholar
• BARAS, B., BENOIT, M.A., DUPRE, L., POULAIN-GODEFROY, 0., SCHACHT, A. M., CAPRON, A., GILLARD, J., and RIVEAU, G., 1999, Single-dose mucosal immunization with biodegradable microparticles containing a Schistosoma mansoni antigen. Infection and Immunity, 67, 2643–2648.
   Google Scholar
• BARAS, B., BENOIT, M. A., YOUAN, B. B. C., and GILLARD, J., 1997b, Spray-dried polylactide and poly(lactide-co-glycolide) microparticles in controlled oral vaccine delivery. Journal of Controlled Release, 48, 289–290.
   Google Scholar
• BARAS, B., BENOIT, M.A., YOUAN, B. B. C., RIVEAU, G., GILLARD, J., and CAPRON, A., 1997a, Vaccine against Schistosomiasis with spray-dried microparticles. Proceedings of the International Symposium on Controlled Release Bioactive Materials, 24, 815–816.
   Google Scholar
• BENOIT, M. A., BARAS, B., and GILLARD, J., 1999, Preparation an characterization of protein-loaded poly(e-caprolactone) microparticles for oral vaccine delivery. International Journal of Pharmaceutics, 184, 73–84.
   PubMedGoogle Scholar
• BENOIT, M. A., BARAS, B., POULAINGODEFROY, 0., SCHACHT, A. M., CAPRON, A., GILLARD, J., and RIVEAU, G., 1998, Evaluation of the antibody response after oral immunization by microparticles containing an antigen from Schistosoma mansoni. In Biomedical Science and Technology: Recent developments in pharmaceutical and medical science, edited by A. Hincal and S. Kas (New York: Plenum Press), pp. 137–144.
   Google Scholar
• BODMEIER, R., and CHEN, H., 1988, Preparation of biodegradable poly(±)lactide microparticles using a spray-drying technique. Journal of Pharmaceutical Pharmacology, 40, 754–757.
   PubMedGoogle Scholar
• CHANG, T. M. S., 1976, Biodegradable semipermeable microcapsules containing enzymes, vaccines, and other biologicals. Journal of Bioengineering, 1, 25–32.
   PubMedGoogle Scholar
• CLARKE, N., O'CONNOR, K., and RAMTOOLA, Z., 1998, Influence of formulation variables on the morphology of biodegradable microparticles prepared by spray drying. Drug Development and Industrial Pharmacy, 24, 169–174.
   Google Scholar
• COHEN, S., YOSHIOKA, T., LUCARELLI, M., HWANG, L. H., and LANGER, R., 1991, Controlled delivery systems for proteins based on poly(lactide/glycolide acid) microspheres. Pharmaceutical Research, 8, 713–720.
   PubMed Web of Science ®Google Scholar
• CONTE, U., CONTI, B., GIUNCHEDI, P., and MAGGI, L., 1994, Spray-dried polylactide microsphere preparation: influence of the technological parameters. Drug Development and Industrial Pharmacy, 20, 235–258.
   Google Scholar
• ELDRIDGE, J. H., GILLEY, R. M., STAAS, J. K., MOLDOVEANU, Z., MEULBROEK, J. A., and TICE, T. R., 1989, Biodegradable microspheres: vaccine delivery system for oral immunisation. Current Topics in Microbiology and Immunology, 146, 59–66.
   PubMedGoogle Scholar
• ELDRIDGE, J. H., HAMMOND, C. J., and MEULBROEK, J. A., 1990, Controlled vaccine release in the gut-associated lymphoid tissue. I. Orally administered biodegradable microspheres target the Peyer's patches. Journal of Controlled Release, 11, 205–214.
   Google Scholar
• ELDRIDGE, J. H., STASS, J. K., MEULBROEK, J. A., TICE, T. R., and GILLEY, R. M., 1991, Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Infection and Immunity, 59, 2978–2986.
   PubMedGoogle Scholar
• GANDER, B., THOMASIN, C., MERKLE, H. P., MEN, Y., and CORRADIN, G., 1993, Pulsed tetanus toxoid release from PLGA-microspheres and its relevance for immunogenicity in mice. Proceedings of the International Symposium on Controlled Release of Bioactive Materials, 20, 65–66.
   Google Scholar
• GANDER, B., WEHRLI, E., ALDER, R., and MERKLE, H. P., 1995, Quality improvement of spray-dried protein loaded (T291)D,(T291)L-PLA microspheres by appropriate polymer solvent selection. Journal of Microencapsulation, 12, 83–97.
   PubMedGoogle Scholar
• GIUNCHEDI, P., CONTI, B., MAGGI, L., and CONTE, U., 1994, Cellulose acetate butyrate and polycaprolactone for ketoprofen spray-dried microsphere preparation. Journal of Microencapsulation, 11, 381–393.
   PubMed Web of Science ®Google Scholar
• Honk, M. S., RANA, R. K., NUNBERG, J. H., TICE, T. R., GILLEY, R. M., and HUDSON, M. E., 1990, Release of human serum albumin from poly(lactide-co-glycolide) micro-spheres. Pharmaceutical Research, 7, 1190–1194.
   PubMedGoogle Scholar
• JEFFERY, H., DAVIS, S. S., and O'HAGAN, D. T., 1991, The preparation and characterization of poly(lactide-co-glycolide) microparticles. I: Oil-in-water emulsion solvent evaporation. International Journal of Pharmaceutic, 77, 169–175.
   Google Scholar
• JEFFERY, H., DAVIS, S. S., and O'HAGAN, D. T., 1993, The preparation and characterization of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharma-ceutical Research, 10, 362–367.
   Google Scholar
• KREUTER, J., and LIEHL, E., 1978, Protection induced by inactivated influenza virus vaccines with polymethylmethacrylate adjuvants. Medical Microbiology and Immunology, 165, 111–117.
   PubMedGoogle Scholar
• LAEMMLI, U. K., 1970, Cleavage of structural proteins during the assembly of the bacteriophage T4. Nature, 277, 680–685.
   Google Scholar
• LOWRY, 0. H., ROSEBROUGH, N. J., FARR, A. L., and RANDALL, R. J., 1951, Protein measurement with Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   Google Scholar
• MUMENTHALER, M., Hsu, C. C., and PEARLMAN, R., 1994, Feasibility study 011 spray-drying protein pharmaceuticals: recombinant human growth hormone and tissue-type plasminogen activator. Pharmaceutical Research, 11, 12–20.
   PubMedGoogle Scholar
• O'FARRELL P. Z., GOODMAN, H. H., and O'FARREL, P. H., 1977, High resolution two-dimensional electrophoresis of basic as well as acidic proteins. Cell, 12, 1133–1142.
   Google Scholar
• O'HAGAN, D. T., 1994, Microparticles as oral vaccines. In Novel delivery systems far oral vaccines, edited by D. T. O'Hagan (Boca Raton: CRC Press), pp. 171–200.
   Google Scholar
• O'HAGAN, D. T., JEFFERY, H., ROBERTS, M. J. J., MCGEE, J. P., and DAVIS, S. S., 1991a, Controlled release microparticles for vaccine development. Vaccine, 9, 768–771.
   Google Scholar
• O'HAGAN, D. T., RAHMAN, D., McGEE, J. P., JEFFERY, H., DAVIES, M. C., WILLIAMS, P., DAVIS, S. S., and CHALLACOMBE, S. J., 1991b, Biodegradable microparticles as controlled-release antigen delivery systems. Immunology, 73, 239–242.
   Google Scholar
• PARK, T. G., Lu, W., and CROTTS, G., 1995, Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly(D,L-lactic acid-co-glycolic acid) microspheres. Journal of Controlled Release, 33, 211–222.
   Web of Science ®Google Scholar
• PAVANETTO, F., CONTI, B., GENTA, I., and GIUNCHEDI, P., 1992, Solvent evaporation, solvent extraction and spray drying for polylactide microsphere preparation. International Journal of Pharmaceutics, 84, 151–159.
   Web of Science ®Google Scholar
• PAVANETTO, F., GENTA, I., GIUNCHEDI, P., and CONTI, B., 1993, Evaluation of spray drying as a method for polylactide and polylactide-co-glycolide microsphere preparation. Journal of Mkroencapsulation, 10, 487–497.
   PubMedGoogle Scholar
• YOUAN, B. B. C., BENOIT, M. A., BABAS, B., and GILLARD, J., 1999, Protein-loaded poly(e-caprolactone). I—Optimization of the preparation by (water-in-oil)-in-water emulsion solvent evaporation. Journal of Microencapsulation, 16, 587–599.
   PubMedGoogle Scholar